Director · Arcutis Biotherapeutics, Inc. · Arcutis Biotherapeutics, Inc. — Stock Option (right to buy)
Side
A
Value
—
Shares
20.5K
Price
—
Executed
Oct 23, 2026
Disclosed
Oct 28, 2026
Disclosure timeline5 days from execution to publication · legal deadline 2 business days
Oct 23 executedOct 28, 2026 disclosed
ARQT · daily
Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Grant or award — administrative, little informational value
Relative size+1 / 25
No reported dollar value · new position
Filing timing+6 / 15
Disclosed 3 business days after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Arcutis Biotherapeutics, Inc. — Stock Option (right to buy)
Ticker
ARQT
Shares
20.5K
Price per share
$0
Execution date (reported)
Oct 23, 2026
Owned after transaction
20.5K shares
Days from execution to publication
5
What this establishes
Scott Robert A filed this Form 4 reporting a grant or award of ARQT on Oct 23, 2026. It became public on Oct 28, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Director
Scott Robert Acik:0001248520
Issuer
Arcutis Biotherapeutics, Inc.cik:0001787306
Revision history · 0
No field has changed since this record was first ingested.
